Tr1-Specific Tolerance: A Novel Treatment of Multiple Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/129/15/14

Funding

  • Radikal Therapeutics Inc (Agmt Signed 9/5/14)
  • National Institute of Neurological Disorders and Stroke (Agmt Signed 9/5/14)